Cytokinetics (CYTK) Tops Q4 EPS by 6c
Tweet
Share
E-mail
Get Alerts CYTK Hot Sheet
Price: $86.34 +1.27%
Revenue Growth %: -75.4%
Financial Fact:
General and administrative: 7.22M
Today's EPS Names:
PKE, LNN, More
Revenue Growth %: -75.4%
Financial Fact:
General and administrative: 7.22M
Today's EPS Names:
PKE, LNN, More
Join SI Premium – FREE
Cytokinetics (NASDAQ: CYTK) reported Q4 EPS of ($1.50), $0.06 better than the analyst estimate of ($1.56). Revenue for the quarter came in at $17.76 million versus the consensus estimate of $7.12 million.
For earnings history and earnings-related data on Cytokinetics (CYTK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta CEO Mark Zuckerberg Says In Internal Town Hall That Ai Agent Development Over The Last Four Months Hasn't 'accelerated In The Way We Expected' - Reuters
- Goldhills Holding Ltd Announces Proposed Debt Settlement
- Skymantics Wins $9.1M IRS Contract to Expand AI-Powered Synthetic Data Engine
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
